Allstate (ALL) PT Raised to $152 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ALL Hot Sheet
Price: $269.06 +2.89%
Rating Summary:
15 Buy, 20 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Rating Summary:
15 Buy, 20 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 29 | New: 13
Join SI Premium – FREE
UBS analyst Brian Meredith raised the price target on Allstate (NYSE: ALL) to $152.00 (from $140.00) while maintaining a Buy rating.
You May Also Be Interested In
- Allstate (ALL) Tops Q3 EPS by $2.99, Beats on Revenue
- PhysicsWallah Ltd (PWL:IN) PT Raised to INR140 at Goldman Sachs
- Procore Technologies, Inc (PCOR) PT Raised to $90 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
